Jose Manuel Zubeldia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jose Manuel Zubeldia has a total of 230 co-authors. Here are the top co-authors by number of shared publications:
- M. Luisa Baeza
Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
10 shared publications - Victor Matheu
Department of Allergy, Hospital Universitario de Canarias, 38320 San Cristóbal de La Laguna, Spain
7 shared publications M. Rubio
5 shared publications- Laura Conejero
Inmunotek S.L., 28805 Madrid, Spain
4 shared publications - M. De Barrio
Allergy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
4 shared publications - Alberto Alvarez-Perea
Allergy Service Hospital General Universitario Gregorio Marañón Madrid Spain
3 shared publications
Latest Publications
- 12 August 2025
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 187 (5) , 468-478
Anisakis simplex Excretion/Secretion Antigens Abolish the Anaphylactic Response in Allergic Mice
Introduction: Helminths’ products modulate the allergic response. We aimed to analyze the inhibitory effect of Ascaris lumbricoides, Anisakis simplex, and A. simplex excretion/secretion (E/S) antigens in a peanut-induced anaphylaxis mouse model. Methods: Four groups of nine C3H/HeOuJ mice were weekly sensitized with intraperitoneal (i.p.) peanut extract (P) for 3 weeks. Concomitantly, first group was daily treated with i.p. A. simplex somatic extract, second group with A. lumbricoides somatic extract, third group with A. simplex E/S extract (P/AK-ES), and a fourth group with saline (P/saline). Nine more mice were non-sensitized (i.p. saline) and used as control group (N/saline). After 5 weeks, anaphylaxis was induced with i.p. peanut extract and evaluated by the recognition of clinical symptoms and body temperature measurements. Specific IgG1, IgG2a, and IgE and cytokines were measured. Results: Non-treated peanut-sensitized mice developed anaphylactic reactions following antigen challenge. Helminth crude extract-treated groups presented moderate symptoms. Nevertheless, P/AK-ES mice almost abolished the anaphylactic symptoms and impeded temperature drop after the challenge. All peanut-sensitized mice developed peanut-specific immunoglobulins. Helminth-treated groups showed an increase of specific IgG1 and IgG2a that peaked on weeks 3 and 4. By contrast, A. simplex E/S extract that hampered the production of specific IgE was observed in mice. Cytokines revealed a significant decrease in IL-5 and a significant increase in IL-10 and IFN-γ in the P/AK-ES group. Conclusions: A. simplex E/S antigens have a potent and effective restraining effect on modulating peanut-induced anaphylaxis in mice.
- 12 August 2025
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 187 (5) , 468-478
Anisakis simplex Excretion/Secretion Antigens Abolish the Anaphylactic Response in Allergic Mice
Introduction: Helminths’ products modulate the allergic response. We aimed to analyze the inhibitory effect of Ascaris lumbricoides, Anisakis simplex, and A. simplex excretion/secretion (E/S) antigens in a peanut-induced anaphylaxis mouse model. Methods: Four groups of nine C3H/HeOuJ mice were weekly sensitized with intraperitoneal (i.p.) peanut extract (P) for 3 weeks. Concomitantly, first group was daily treated with i.p. A. simplex somatic extract, second group with A. lumbricoides somatic extract, third group with A. simplex E/S extract (P/AK-ES), and a fourth group with saline (P/saline). Nine more mice were non-sensitized (i.p. saline) and used as control group (N/saline). After 5 weeks, anaphylaxis was induced with i.p. peanut extract and evaluated by the recognition of clinical symptoms and body temperature measurements. Specific IgG1, IgG2a, and IgE and cytokines were measured. Results: Non-treated peanut-sensitized mice developed anaphylactic reactions following antigen challenge. Helminth crude extract-treated groups presented moderate symptoms. Nevertheless, P/AK-ES mice almost abolished the anaphylactic symptoms and impeded temperature drop after the challenge. All peanut-sensitized mice developed peanut-specific immunoglobulins. Helminth-treated groups showed an increase of specific IgG1 and IgG2a that peaked on weeks 3 and 4. By contrast, A. simplex E/S extract that hampered the production of specific IgE was observed in mice. Cytokines revealed a significant decrease in IL-5 and a significant increase in IL-10 and IFN-γ in the P/AK-ES group. Conclusions: A. simplex E/S antigens have a potent and effective restraining effect on modulating peanut-induced anaphylaxis in mice.
- Open Access
- 7 February 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (2) , 647-650
Corrections
- 7 February 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (2) , 647-650
Open AccessCorrections
- 1 September 2021
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 61 (5) , 340-341
Immunologic assessments from ARTEMIS: A European, phase 3, randomized, double-blind, placebo-controlled trial of AR101 in peanut-allergic subjects aged 4–17 years
- 1 September 2021
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 61 (5) , 340-341
Immunologic assessments from ARTEMIS: A European, phase 3, randomized, double-blind, placebo-controlled trial of AR101 in peanut-allergic subjects aged 4–17 years
Food protein‐induced enterocolitis syndrome by fish: Not necessarily a restricted diet
Food protein‐induced enterocolitis syndrome (FPIES) is a non‐IgE‐mediated gastrointestinal food hypersensitivity usually due to cow′s milk or soy. Recent researches show that fish is 1 of the most important triggers of FPIES in the Mediterranean countries. Due to the risk of multiple‐food FPIES, avoiding foods in the same category or that often occur together may be reasonable. The aim of this study was to evaluate the evolution and follow‐up of FPIES related to fish over a period of 20 years. We describe the clinical features of our population, discuss different approaches to oral food challenges, and analyze the possibility of introducing the culprit fish or other nonrelated fish to avoid unnecessary restricted diets.
Food protein‐induced enterocolitis syndrome by fish: Not necessarily a restricted diet
Food protein‐induced enterocolitis syndrome (FPIES) is a non‐IgE‐mediated gastrointestinal food hypersensitivity usually due to cow′s milk or soy. Recent researches show that fish is 1 of the most important triggers of FPIES in the Mediterranean countries. Due to the risk of multiple‐food FPIES, avoiding foods in the same category or that often occur together may be reasonable. The aim of this study was to evaluate the evolution and follow‐up of FPIES related to fish over a period of 20 years. We describe the clinical features of our population, discuss different approaches to oral food challenges, and analyze the possibility of introducing the culprit fish or other nonrelated fish to avoid unnecessary restricted diets.
- 1 January 2015
- Vol. 25 (4) , 288-294
Anaphylaxis in Adolescent/Adult Patients Treated in the Emergency Department: Differences Between Initial Impressions and the Definitive Diagnosis
Objectives: To contrast the initial suspected etiology of anaphylaxis with the postworkup diagnosis in patients attended at the emergency department (ED) of a tertiary-level hospital in Spain and to investigate the incidence, causes, and management of anaphylaxis. Methods: We performed an observational study of patients aged more than 15 years who came to the ED with anaphylaxis between 2009 and 2010. All clinical records from the ED were reviewed. We recorded data on clinical management, the etiology proposed by the attending emergency physician, and the cause reported by the patient. The findings were compared with the diagnosis reached after the allergy workup. Results: The incidence of anaphylaxis was 0.08%. The most common manifestation was skin-mucosal symptoms (98.3%). Anaphylaxis was diagnosed in the ED in only 44% of the cases, regardless of severity. Only 39.7% received epinephrine, which was administered more frequently when the ED physician diagnosed anaphylaxis, regardless of severity. A total of 60 patients were subsequently seen at the allergy department. The final etiology differed from the initial suspicion in the ED in 45% of cases. The frequency of anaphylaxis of uncertain origin decreased from 33.3% to 13.3%. After the allergy workup, drugs (41.7%) were considered the main cause of anaphylaxis, followed by food (25%). Conclusions:The incidence of anaphylaxis (0.08%) was double that estimated in the ED. Anaphylaxis is underdiagnosed. A correct diagnosis conditions the administration of epinephrine, regardless of the severity of symptoms. The real etiology of anaphylaxis should only be proposed after an allergy workup, which is recommended in all cases, as the real cause can differ considerably from the initial impression in the ED.
- 1 January 2015
- Vol. 25 (4) , 288-294
Anaphylaxis in Adolescent/Adult Patients Treated in the Emergency Department: Differences Between Initial Impressions and the Definitive Diagnosis
Objectives: To contrast the initial suspected etiology of anaphylaxis with the postworkup diagnosis in patients attended at the emergency department (ED) of a tertiary-level hospital in Spain and to investigate the incidence, causes, and management of anaphylaxis. Methods: We performed an observational study of patients aged more than 15 years who came to the ED with anaphylaxis between 2009 and 2010. All clinical records from the ED were reviewed. We recorded data on clinical management, the etiology proposed by the attending emergency physician, and the cause reported by the patient. The findings were compared with the diagnosis reached after the allergy workup. Results: The incidence of anaphylaxis was 0.08%. The most common manifestation was skin-mucosal symptoms (98.3%). Anaphylaxis was diagnosed in the ED in only 44% of the cases, regardless of severity. Only 39.7% received epinephrine, which was administered more frequently when the ED physician diagnosed anaphylaxis, regardless of severity. A total of 60 patients were subsequently seen at the allergy department. The final etiology differed from the initial suspicion in the ED in 45% of cases. The frequency of anaphylaxis of uncertain origin decreased from 33.3% to 13.3%. After the allergy workup, drugs (41.7%) were considered the main cause of anaphylaxis, followed by food (25%). Conclusions:The incidence of anaphylaxis (0.08%) was double that estimated in the ED. Anaphylaxis is underdiagnosed. A correct diagnosis conditions the administration of epinephrine, regardless of the severity of symptoms. The real etiology of anaphylaxis should only be proposed after an allergy workup, which is recommended in all cases, as the real cause can differ considerably from the initial impression in the ED.
- 1 November 2014
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 2 (6) , 800-802
Acute generalized exanthematous pustulosis due to benznidazole
- 1 November 2014
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 2 (6) , 800-802
Acute generalized exanthematous pustulosis due to benznidazole
- Open Access
- 17 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e91996
Gene Silencing of SOCS3 by siRNA Intranasal Delivery Inhibits Asthma Phenotype in Mice
Suppresors of cytokine signaling (SOCS) proteins regulate cytokine responses and control immune balance. Several studies have confirmed that SOCS3 is increased in asthmatic patients, and SOCS3 expression is correlated with disease severity. The objective of this study was to evaluate if delivering of SOCS3 short interfering RNA (siRNA) intranasally in lungs could be a good therapeutic approach in an asthma chronic mouse model. Our results showed that intranasal treatment with SOCS3-siRNA led to an improvement in the eosinophil count and the normalization of hyperresponsiveness to methacholine. Concomitantly, this treatment resulted in an improvement in mucus secretion, a reduction in lung collagen, which are prominent features of airway remodeling. The mechanism implies JAK/STAT and RhoA/Rho-kinase signaling pathway, because we found a decreasing in STAT3 phosphorylation status and down regulation of RhoA/Rho-kinase protein expression. These results might lead to a new therapy for the treatment of chronic asthma.
- 17 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e91996
Open AccessGene Silencing of SOCS3 by siRNA Intranasal Delivery Inhibits Asthma Phenotype in Mice
Suppresors of cytokine signaling (SOCS) proteins regulate cytokine responses and control immune balance. Several studies have confirmed that SOCS3 is increased in asthmatic patients, and SOCS3 expression is correlated with disease severity. The objective of this study was to evaluate if delivering of SOCS3 short interfering RNA (siRNA) intranasally in lungs could be a good therapeutic approach in an asthma chronic mouse model. Our results showed that intranasal treatment with SOCS3-siRNA led to an improvement in the eosinophil count and the normalization of hyperresponsiveness to methacholine. Concomitantly, this treatment resulted in an improvement in mucus secretion, a reduction in lung collagen, which are prominent features of airway remodeling. The mechanism implies JAK/STAT and RhoA/Rho-kinase signaling pathway, because we found a decreasing in STAT3 phosphorylation status and down regulation of RhoA/Rho-kinase protein expression. These results might lead to a new therapy for the treatment of chronic asthma.